Enigmatic Histamine Receptor H4 for Potential Treatment of Multiple Inflammatory, Autoimmune, and Related Diseases.
Przemysław MisztaPrzemysław MisztaPrzemysław RzodkiewiczOlga MichalakPiotr KrzeczyńskiSławomir FilipekPublished in: Life (Basel, Switzerland) (2020)
The histamine H4 receptor, belonging to the family of G-protein coupled receptors, is an increasingly attractive drug target. It plays an indispensable role in many cellular pathways, and numerous H4R ligands are being studied for the treatment of several inflammatory, allergic, and autoimmune disorders, including pulmonary fibrosis. Activation of H4R is involved in cytokine production and mediates mast cell activation and eosinophil chemotaxis. The importance of this receptor has also been shown in inflammatory models: peritonitis, respiratory tract inflammation, colitis, osteoarthritis, and rheumatoid arthritis. Recent studies suggest that H4R acts as a modulator in cancer, neuropathic pain, vestibular disorders, and type-2 diabetes, however, its role is still not fully understood.
Keyphrases
- neuropathic pain
- rheumatoid arthritis
- oxidative stress
- type diabetes
- respiratory tract
- pulmonary fibrosis
- spinal cord
- spinal cord injury
- cardiovascular disease
- emergency department
- papillary thyroid
- combination therapy
- replacement therapy
- knee osteoarthritis
- climate change
- idiopathic pulmonary fibrosis
- skeletal muscle